CHAPTER 8. orthopaedic and bone tissue engineering applications.

Similar documents
Study the effect of chitosan on adhesion, proliferation and osteoblast differentiation of bone marrow derived human mesenchymal stem cells

Biochemical and Biophysical Research Communications

Application Note. Introduction. Kerry Thompson, Jeff Partridge, Paula Flaherty, Susan Qian, and Deepa Saxena

Pittsburgh Tissue Engineering Initiative Annual Progress Report: 2011 Formula Grant

A NANOFIBROUS HYDROGEL FOR BONE TISSUE ENGINEERING

Osteogenic Differentiation and Analysis of MSC

Osteoblast Differentiation and Mineralization

Lab Module 7: Cell Adhesion

Cell Adhesion Assay performed on Tecom Dental Implants Customer: Titanmed s.r.l.

PRINCIPLES AND PRACTICE OF TISSUE ENGNEERING:

Cross-Linker Modulation to Maintain Phenotype of RGD-Alginate-Embedded Mesenchymal Stem Cells

Stem cells and tissue engineering

Affinity. A Paradigm Shift in Skeletal Reconstruction

Formation of Mesenchymal Tissues in Alvetex Scaffold Derived From Stem Cells and Established Cell Lines. Introduction

References. 1 Department of Biotechnology and Medical Engineering, National Institute of Technology

Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis

International Journal of Pharma and Bio Sciences

A Straw-Housed Paper-based Colorimetric Antibody-antigen Sensor

At the conclusion of this lesson you should be able to:

Assuring Multipotency of human Mesenchymal Stem Cells (hmsc)

Seevix s SVXgro: A Spidersilk Scaffold for Tissue Engineering

Mesenchymal Stem Cells

Nanocrystalline apatite: from fundamentals to bone substitute materials Industrial and business point of view

Serum-Free, Xeno-Free Differentiation Media. for Human Mesenchymal Stem Cells

PROTOCOL. Collagen I Thin Gel Coating of Alvetex Scaffold. Introduction. Method. Page 1

Lyset BOOST YOUR CELL CULTURE TODAY FOR THE EXPERIMENTS OF TOMORROW

Methods in Bioengineering: 3D Tissue Engineering

Human Bone Marrow Derived Mesenchymal Stem Cell (MSC) Care Manual

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:

Kit Components (Included) Cat # # of vials Product Name Quantity Storage Human Renal Cortical Epithelial Cells (HRCEpiC)

CHAPTER 4 IN VITRO CYTOTOXICITY ASSAY ON GOLD NANOPARTICLES WITH DIFFERENT STABILIZING AGENT

CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration

Investigating bone mineral formed by different cell types in bone tissue engineering

3 Functional role of scaffolds with different geometries as a template for physiological callus formation: evaluation of collagen 3D assembly 1

UK +44 (0) CH +41 (0) DE +49 (0) US

User Manual. OriCell TM Mesenchymal Stem Cell Osteogenic Differentiation Medium. Cat. No. GUXMX-90021

A Comparative Study of Upconverting Nanoparticles Versus Lentiviral GFP Transduction for Labeling Mesenchymal Stem Cells

Human ipsc-derived Renal Proximal Tubular Cells. Protocol version 1.0

ELISPOT antibody pair Technical Data Sheet

The Construction of Cell-Density Controlled Three- Dimensional Tissues by Coating Micrometer-Sized Collagen. Fiber Matrices on Single Cell Surfaces

Pittsburgh Tissue Engineering Initiative Annual Progress Report: 2010 Formula Grant

Negatively charged microspheres provide an additional surface for cell attachment leading to proliferation, tissue regeneration and wound healing

Application Note. BD PureCoat ECM Mimetic Cultureware Collagen I Peptide: Novel Synthetic, Animal-free Surface for Culture of Human Keratinocytes

Application Note 493

Supplementary Data. In Vivo Bone Formation by impcs Materials and methods. Results. Conclusions

Enzyme-mediated preparation of hydrogels composed of poly(ethylene glycol) and gelatin as cell culture platforms

Cell Migration, Chemotaxis and Invasion Assay Using Staining

User Manual. OriCell TM Human Umbilical Cord Blood Mesenchymal Stem Cells. Cat. No. HUXUB-01001

SUPPLEMENTAL MATERIAL. Supplemental Methods:

Real-Time Vital Mineralization Detection and Quantification during In Vitro Osteoblast Differentiation

g: relative centrifugal force R: radius of the rotor S: speed of the centrifuge in revolutions per minute

PROTOCOL. Live Cell Imaging of 3D Cultures Grown on Alvetex Scaffold Using Confocal Microscopy. Introduction

Effects of Substrate Morphology on Osteoblastic Response to Thin Film Calcium Phosphate Coatings F. Horgan 1, B.J. Meenan 1 1

INVESTIGATION OF MSC DIFFERENTIATION ON ELECTROSPUN NANOFIBROUS SCAFFOLDS

Matrices sourcebook. Your guide to Gibco extracellular matrices products

3D Cell Culture Product Intro. Bio-Byblos Biomedical

1) Determining the best cell sources and scaffold materials for TEHV development.

In Vitro Angiogenesis Assay Kit

Background. Background. Background. Background. Background 3/4/2013

User Manual. OriCell TM Rabbit Mesenchymal Stem Cells (MSCs) Cat. No. RBXMX-01001

Supporting Information. Templated Repair of Long Bone Defects in Rats. with Bioactive Spiral-Wrapped Electrospun

Polymer Nanocomposites for Medical Applications

PREPARATION AND CHARACTERIZATION OF HYDROXYAPATITE FROM FISHBONE

Matrices Sourcebook Life Technologies extracellular matrices products

Thirupathi Kumara Raja. S, 1 Thiruselvi. T, 1 Asit Baran Mandal, 1 Gnanamani. A, 1* Adyar, Chennai Tamil Nadu, India

Keywords : Bacterial cellulose, Dielectric barrier discharge (DBD) plasma, Gelatin, Acetobacter xylinum ABSTRACT

Supplemental Information. Materials and methods.

Supplementary Table 1. PCR amplification conditions for each primer pair. Primer sequence

Ver.03. For Research Use Only

Mesenchymal stem cell culture Flow cytometry Analysis and improvement of the cell modification using flow cytometry Site density determination

A biomaterials approach to influence stem cell fate in injectable cell-based therapies

Quantum Dot Labeling of Stem Cells during Proliferation and Differentiation

If protein coating is acceptable in the planned experiments, there is another quick and simple way to render the surface hydrophilic.

All quality control test results are reported on a lot specific Certificate of Analysis which is available at or upon request.

Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota

REMEDI. Regenerative Medicine Institute (REMEDI) NUI Galway, Ireland GENERAL PRESENTATION. Director: Prof. Frank Barry

T ECHNICAL MANUAL. Culture of Human Mesenchymal Stem Cells Using MesenCult -XF Medium

CHARACTERIZATION AND APPLICATION OF COLLAGEN-POLYMER BASED COMPOSITE AS WOUND HEALING MATERIAL

UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE MEDICINE

Monteiro, G., Sundararaghavan, H. Fernandes, A. and Shreiber, D. Rutgers, the State University of New Jersey, New Brunswick, NJ, USA

Adipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords

Growth factor delivery

COMPARISON OF NANOPOROUS SCAFFOLDS MANUFACTURED BY ELECTROSPINNING AND NANOFIBRILLAR COMPOSITE CONCEPT

The Healing Of Tibial And Calvarial Defect Using Runx2-transfected Adipose Stem Cells

The BioFlux 200 System Using Well Plate Microfluidics for Live Cell Assays Product Overview and Tutorial

BD MOSAIC h MSC CELL CULTURE ENVIRONMENT DEFINED SERUM FREE

All quality control test results are reported on a lot specific Certificate of Analysis which is available at or upon request.

Supporting Information. Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis,

The Effect of Mesenchymal Stem Cell Migration and Adhesion on Demineralized Bone Scaffolds under Vacuum Infusion Packaging Technology.

Data Sheet. TCR activator / PD-L1 - CHO Recombinant Cell line Cat. #: 60536

Supplementary Information. Conversion of vascular endothelial cells into multipotent stem-like cells

BD PureCoat ECM Mimetic Cultureware. Natural Performance. Scientifically Defined.

B. ADM: C. D. Apoptosis: 1.68% 2.99% 1.31% Figure.S1,Li et al. number. invaded cells. HuH7 BxPC-3 DLD-1.

DYNARRAYS - Microcavity Arrays

BD IMag. Streptavidin Particles Plus - DM. Technical Data Sheet. Product Information

Electron Microscopy Sciences

Expansion of Human Mesenchymal Stem Cells Using Corning HYPER Technology Cell Culture Vessels

Tissue Engineering. Mesenchymal Stem Cells for. Tissue Engineering

Attenuation of MSC Hypertrophy in 3D Culture via Treatment with a Retinoic Acid Receptor Inverse Agonist

Exogenous Horseradish Peroxidase Improved Mechanical Properties and Cell Viability in Hyaluronan Scaffolds

Transcription:

CHAPTER 8 Study the synergistic effect of collagen type I, hyaluronic acid and chitosan on adhesion, proliferation and osteoblast differentiation of bone marrow derived human mesenchymal stem cells. 8.1 Introduction The Extra cellular matrix (ECM) components are considered as good candidates for fabricating scaffolds with superior bioactivity or functionalizing biomaterials to improve their performance (Green, 2008). A biomimetic surface coating to improve or enhance the osteoconductivity of biomaterials and tissue engineering scaffolds holds great promise in orthopaedic and bone tissue engineering applications. Among the ECM, collagen type 1 accounts for 90% of organic matrix of bone and plays a significant role in mineralization (Zhu et al., 2009). Our previous data on the role of major ECM proteins on proliferation and osteoblast differentiation of hmscs (Chapter 5) showed that collagen type I enhanced hmscs proliferation, accelerated, and enhanced mineralization. Compared to untreated and other ECM protein treated plates, collagen type I treated plates reduced the doubling time of hmscs significantly. In addition, there was early onset of mineralization and enhanced bone matrix deposition on collagen type I treated plates. However, the amount of calcium in the secreted matrix was not significantly higher than the untreated plates. Hyaluronic acid (HA) is also a major component of the ECM of many cells including fibroblasts (Fraser et al., 1997). They play a significant role in cell proliferation, migration (Koochekpour et al., 1995) and wound healing (Lin, 2009). Manferdini et al 126

(2010) reported enhanced mineralization by hmscs on a biomimetic hyaluronic acid based scaffolds. Our previous data on the effect of various glycosaminoglycans (GAGs) on proliferation and osteoblast differentiation of hmscs demonstrated significant enhancement of osteoblast differentiation and mineralization on HA treated plate (Chapter 6). HA treated plates showed significant mineralization in the early phase of differentiation and the secreted bone matrix showed fourfold increase in the calcium content when compared to the untreated plate. However HA did not enhance hmsc proliferation but rather there was a slight reduction in cell viability and an increase in the doubling time. Chitosan is a natural cationic polymer with a structural similarity to the hyaluronic acid of ECM (Peniche et al., 2007) and are known to accelerate wound healing and influence tissue regeneration (Kim et al., 2008). Chitosan is widely used as a scaffold for bone tissue engineering and is shown to enhance osteogenesis (Yang et al., 2009; Venkatesan and Kim, 2010). We also demonstrated the enhancement of osteoblast differentiation and mineralization of hmscs on chitosan treated plates (Chapter 7). Chitosan significantly enhanced mineralization and developed highly mineralized bone nodule like structures. There was marked increase for calcium present in the secreted mineral matrix on chitosan treated plates when compared to the untreated plate. Although there was good cell viability on chitosan treated plate, it did promote cell adhesion greatly. Based on the our previous studies, we have selected chitosan, the natural polymer with good film forming capacity and osteogenic potential; collagen type 1, which enhanced the cell adhesion as well as bone matrix synthesis; and HA, which enhanced mineralization and secreted high calcium containing bone matrix, for a tripolymer combination to get the synergistic effect of these polymers in osteogenesis. In the present 127

study we are trying to understand the beneficial effect of tripolymer biomimetic coating system using a combination of chitosan, collagen type 1and hyaluronic acid to enhance osteoblast differentiation and mineralization of human bone marrow derived mesenchymal stem cells. The chitosan-collagen-hyaluronic acid based scaffolds, exploits the biomimetic approach of tissue engineering and there by promises better osteogenesis and bone regeneration. Combined chitosan collagen matrices promoted osteoblast differentiation of MSCs, and improved the mechanical and physical properties of the sponges (Arpornmaeklong et al., 2008). Chitosan gelatine surface modification with hyaluronic acid improved fibroblast adhesion (Mao et al., 2003). Here, we optimize the concentration and ratio of mixing each component and method of coating in order to achieve an enhanced differentiation. This tripolymer coating could be used as an osteoconductive coating for implants and scaffolds to improve their osteointegration. 8.2 Materials and methods 8.2.1 Preparation of chitosan, collagen type I and hyaluronic acid solutions The Chitosan (CHI) powder (>87.61% degree of deacetylation, DD) which was a kind gift from Indian Sea Foods (Cochin, India) was purified before use by repeated precipitation with 10% NaOH (Merck, India). Hyaluronic acid (HA) from human umbilical cord and collagen type 1(COL) from calf skin were purchased from Sigma Aldrich (St. Louis, MO, USA). One percentage CHI solution was prepared by autoclaving purified CHI powder in distilled water and then dissolving it by adding 1M sterile glacial acetic acid (Merck, India). One percentage COL solution was prepared by adding 0.1M sterile glacial acetic acid. One percentage HA solution was prepared in sterile HEPES buffered saline (Sigma Aldrich, St. Louis, MO, USA). The coating density 128

of CHI, COL and HA, which supported hmsc adhesion and proliferation, was standardized to 25, 6 and 50µg per sq.cm respectively (Data not shown). Based on this the working solutions of CHI (0.5mg/ml), COL(0.12mg/ml) and HA (1mg/ml) were prepared and used for further combination coatings under laminar flow hood in order to maintain sterility. A coating volume of 50µl per sq. cm of the surface area was used for coating the tissue plate surface (BD Biosciences, USA). 8.2.2 Preparation of single polymer coated plates The single polymer coated plates were prepared by covering the tissue culture plates with the polymer solutions of CHI (0.5mg/ml), COL (0.12mg/ml) and HA (1mg/ml) to give a final coating density of 12, 25 and 50 µg per sq. cm respectively. The plates were allowed to dry at 37 0 C in an incubator. The acidity of the chitosan coated plates was neutralized with 0.1M NaOH solution. All the coated plates were first rinsed with distilled water and then with Dulbecco s phosphate buffered saline (DPBS; GIBCO, Invitrogen, NY, USA) before seeding the cells. 8.2.3 Tripolymer coating by polyblend method The polyblend solution was prepared by mixing CHI (0.5mg/ml) and COL (0.12mg/ml) solutions at different mixing ratios given in table 8.1. This solution was blended in a magnetic stirrer for 6h at RT. To this clear solution of CHI-COL, 1mg/ml of HA was added slowly to make a tripolymer solution. This tripolymer solution was blended in a magnetic stirrer for another 6h at RT. This gave a turbid solution. The tissue culture plates were coated with the tripolymer polyblend solution and were allowed to dry at 37 0 C in an incubator. The coated plates were rinsed with distilled water and then with DPBS before seeding the cells. These plates will be referred to as polyblend coated plates and represented as (CHI: COL: HA)-P henceforth. 129

Method of coating Polyblend method Surface modification method Controls Mixing ratio (CHI:COL:HA) Plate label CHI (0.5mg/ml) COL (0.12mg/ml) HA (1mg/ml) (1CHI:1COL:1HA)-P 1 1 1 (3CHI:2COL:4HA)-P 3 2 4 (3CHI:1COL:5HA)-P 3 1 5 (3CHI:4COL:2HA)-P 3 4 2 (3CHI:5COL:1HA)-P 3 5 1 (2CHI:3COL:4HA)-P 2 3 4 (1CHI:3COL:5HA)-P 1 3 5 (5CHI:3COL:1HA)-P 5 3 1 (4CHI:3COL:2HA)-P 4 3 2 (4CHI:2COL:3HA)-P 4 2 3 (5CHI:1COL:3HA)-P 5 1 3 (1CHI:5COL:3HA)-P 1 5 3 (2CHI:4COL:3HA)-P 2 4 3 (3CHI:1COL:0HA)-P 3 1 0 (1CHI:1COL:0HA)-P 1 1 0 (1CHI:3COL:0HA)-P 1 3 0 (3CHI:0COL:1HA)-P 3 0 1 (1CHI:0COL:1HA)-P 1 0 1 (1CHI:0COL:3HA)-P 1 0 3 ([1CHI:0COL]1HA)-S 1 0 1 ([3CHI:1COL]1HA)-S 3 1 1 ([1CHI:1COL]1HA)-S 1 1 1 ([1CHI:3COL]1HA)-S 1 3 1 ([0CHI:1COL]1HA)-S 0 1 1 ([1CHI:0HA]1COL)-S 1 1 0 ([3CHI:1HA]1COL)-S 3 1 1 ([1CHI:1HA]1COL)-S 1 1 1 ([1CHI:3HA]1COL)-S 1 1 3 ([0CHI:1HA]1COL)-S 0 1 1 CHI 1 0 0 COL 0 1 0 HA 0 0 1 UT 0 0 0 Table 8.1 Mixing ratios of the tripolymer combinations. 8.2.4 Tripolymer coating by surface modification method CHI-COL solutions were made in different mixing ratios mentioned in table 8.1. This solution was blended in a magnetic stirrer for 6h at RT to give a clear solution. 130

Tissue culture plates were first coated with this blend solution of CHI-COL and were allowed to dry in an incubator at 37 0 C. HA solution was then layered over the dry CHI- COL coated plates at a coating density of 50µg per sq.cm. The plates were allowed to dry in an incubator at 37 0 C. The plates were washed with distilled water and with DPBS before seeding the cells. These plates will be referred to as surface modified plates and represented as ([CHI: COL] 1HA)-S henceforth. Untreated normal tissue culture plates (UT), CHI coated, COL coated and HA coated plates served as the controls for the comparative study. 8.2.5 Culture of hmscs on the coated plates Human MSCs were isolated from bone marrow of adult human donors after taking informed written consent by method mentioned under Section 4.3.5. The cells were grown in hmsc media (Table 4.2). Human MSCs were plated at a seeding density of 5000 cells per sq. cm on each of the treated plates. The cells were grown in hmsc media in a humidified incubator maintained at 37 0 C with 5% CO 2 in the air. The plates were observed under a phase contrast microscope (Nikon Eclipse TE2000-S) for cell adherence and morphology. 8.2.6 Osteoblast differentiation studies on the coated plates Human MSCs grown on various coated plates were directed to osteoblast lineage by growing them in osteogenic induction media (Table 4.2). The osteogenic potential of the coated plates were evaluated at different time points by methods like histochemical staining for secreted mineral matrix (Alizarin Red S, Section 4.2.9.3.1 and von Kossa staining, Section 4.2.9.3.2) and calcium assay (Section 5.2.3.4). 131

8.2.7 Statistical analysis The experiments were repeated with three different donor samples. Measures for each sample were performed in triplicates and the results were expressed as mean ± standard deviation (SD). Two tailed, paired Student s t test was used for the statistical analysis and a p-value less than 0.05 was considered significant and asterisks were given accordingly to indicate the level of significance as *p<0.05, **p<0.01 and ***p<0.001. 8.3 Results 8.3.1 Screening of osteoblast differentiation potential A total of 19 polyblend coated plates and 10 surface modified plates with different mixing ratios of CHI, COL and HA were screened for their osteogenic potential by Alizarin Red S staining on day 14 of osteogenic induction (Fig. 8.1). The plates coated with (1CH:1COL:1HA)-P, ([3CHI:1COL] 1HA)-S, ([1CHI:1COL] 1HA)-S, ([1CHI:3COL] 1HA)-S and [0CHI:1COL] 1HA)-S showed positive for Alizarin Red S and were selected for further analysis for this study. The plates coated with single polymer such as CHI, COL and HA also showed positive for Alizarin Red S staining in the screening test. Among the plates surface modified with HA, only ([1CHI:0COL] 1HA)-S did not give a positive screening test however, it was included in this study for further analysis and comparison. 132

Figure 8.1 Screening of tripolymer combination plates for the osteogenic potential. Phase contrast micrographs showing the plates stained with Alizarin Red S stain after 14 days of osteogenic induction (Inset: macroscopic view of the corresponding stained plates). Only two plates among the polyblend coated plate (E, K) gave positive staining; whereas, five surface coated plates (Y, Z, Z1, Z2, Z7) showed positive staining. CHI, COL and HA treated plates also showed positive staining for calcium. Phase contrast micrographs scale bar -50µm. 8.3.2 Human MSC adhesion on the selected tripolymer coated plates All the selected plates provided a suitable surface for hmscs adhesion and proliferation and showed adherent spindle shaped fibroblast like cells after 24 h of seeding (Fig. 8.2). 133

Figure 8.2 hmsc culture on selected tripolymer coated plates. Phase contrast micrographs showing hmscs on the tripolymer coated plates after 24h of seeding. There was cell adhesion to all the coated plates and the cells showed comparable fibroblast like morphology. Scale bar - 50µm. 8.3.3 Osteoblast differentiation assay on the selected tripolymer coated plates Phase contrast microscopy showed mineralization in all the coated plates except ([1CHI:0COL] 1HA)-S on day 14 of osteogenic induction (Fig. 8.3). On day 21, all the tested plates showed marked increase in the mineral deposits. High mineralization was observed on (1CH:1COL:1HA)-P, ([1CHI:1COL] 1HA)-S, ([1CHI:3COL] 1HA)-S, [0CHI:1COL] 1HA)-S, and HA treated plates. 134

Figure 8.3 Osteoblast differentiation of hmscs on tripolymer coated plates. Phase contrast micrographs showing different stages of mineralization. All the coated plates showed initiation of mineralization on day 14 of differentiation, which was enhanced, by day 21. Scale bar -10µm. 8.3.3.1 Alizarin Red S staining for calcium Alizarin Red S staining done on day 14 of differentiation (Fig. 8.4) showed enhancement of osteoblast differentiation on all the selected plates except ([1CHI:0COL]1HA)-S (Fig. 8.4F) where the combination had only chitosan and hyaluronic acid. Alizarin Red S demonstrated the intense staining on ([1CHI:1COL] 1HA)-S and, ([1CHI:3COL] 1HA)-S tripolymer coated plates (Fig. 8.4H, I), indicating more bone matrix formation. 135

Figure 8.4 Alizarin Red S staining for calcium. Representative phase contrast colour micrographs of calcium deposits stained by Alizarin Red S after 14 days of osteogenic induction (Insert: gross view of the corresponding stained plates). All the coated plates except ([1CHI:0COL] 1HA)-S (F) showed a positive staining as well as more mineralization than the untreated plates. Note the higher intensity of staining on the tripolymer coated plates ([1CHI:1COL] 1HA)-S and ([1CHI:3COL] 1HA)-S (H, I). Scale bar-10µm. The staining also revealed better mineralization on the tripolymer coated plates (Fig. 8.4E, G, H and I) when compared to the single polymer coated plates (Fig. 8.4B-D). The bipolymer combination of collagen type1 and hyaluronic acid (Fig. 8.4J) also showed more mineralization than their single polymer coated plates (Fig. 8.4C and D). Among the single polymer coated plates, HA showed significantly higher mineralization than CHI and COL alone or untreated plate (Fig. 8.4D). 136

8.3.3.2 Von Kossa staining for calcium Von Kossa staining which demonstrates the calcium in the secreted mineral matrix towards the final phase of osteoblast differentiation was used to confirm and further compare the mineralization on the selected plates. All the selected plates showed positive Von Kossa staining after 21 days of osteogenic induction (Fig. 8.5). Figure 8.5 Von Kossa staining for calcium. Representative phase contrast colour micrographs of calcium deposits stained by Von Kossa staining method after 21days of osteogenic induction (Inset shows the macroscopic view of the corresponding stained plates). Enhancement of mineralization is appreciated in all the coated plates. Scale bar-10µm. 137

The staining revealed enhancement of mineralization on all the coated plates when compared to the untreated plate. However, the surface modified plate like ([1CHI:1COL] 1HA)-S showed remarkably higher mineral deposition. Among the individual polymer coated plates, HA coated plate showed relatively higher mineral deposition than CHI, COL and untreated coated plate (Fig 8.5 A-D). 8.3.3.3. Calcium assay Quantification of calcium also showed interesting results (Fig.8.6). Figure 8.6 Calcium assay. Graph showing the mean with SD of a representative experiment done in triplicates. The amount of calcium in the secreted matrix was quantified after 21 days of osteogenic induction. There was more amount of calcium in the mineral matrix of all the coated plates when compared to the untreated plate. The tripolymer plate, ([1CHI:1COL] 1HA)-S showed the highest amount of calcium which was significantly higher than the calcium on untreated or individual polymer coated plates. 138

Among the individual polymer coated plates, there was no significant difference in calcium deposition in CHI and COL as compared to the untreated; whereas, HA coated plates significantly improved calcium deposition. Surface modified plates showed significantly high amount of calcium deposition when collagen was present (3.21± 0.0mg in ([1CHI: 1COL] 1HA)-S and 3.00 ± 0.33mg in ([1CHI: 3COL] 1HA)-S as compared to no collagen (1.25± 0.32mg in ([1CHI: 0COL] 1HA)-S, p < 0.05). ([1CHI: 1COL] 1HA)-S plate showed significantly high amount of calcium than CHI, COL, HA alone or untreated plates. Absence of CHI (([0CHI: 1COL] 1HA)-S) or addition of high concentration of CHI ([3CHI:1COL] 1HA)-S) also affected calcium deposition. 8.4 Discussion Composite polymers have always attracted the researchers due to their ability to achieve better mechanical and biological properties than their individual polymers (Rafat et al., 2008; Wang et al., 2003). Chitosan, collagen and hyaluronic acid are widely investigated for their potential use in bone tissue engineering (Sabir et al., 2009). To our knowledge, this is a first study using the combination of these three osteogenic biomaterials for a biomimetic coating of normal tissue culture plates to evaluate their combined effect on the osteogenic differentiation and mineralization of hmscs. Here we have evaluated the synergistic effect of these polymers at different mixing ratios by two different coating methods. We have developed a simple but novel approach of modifying the tissue culture plate, which resulted in the synergistic enhancement of mineralization by a tripolymer combination. First, we optimized the coating density of the individual polymer chitosan, collagen type1 and hyaluronic acid, which favoured hmsc adhesion, proliferation and osteoblast differentiation. This approach helped us in stringent evaluation and comparison 139

of the osteogenic potential of different tripolymer combinations with respect to the contribution of individual components. We also created an apt platform for obtaining a positive complementary effect on osteogenic differentiation. Out of the 13 plates with different combinations and concentrations, coated by the polyblend method, only one plate which had equal mixing ratio of CHI, COL and HA (1CHI:1COL:1HA)-P showed enhanced mineralization. These plates had a final coating density of 8.5, 2, 16.5µg of CHI, COL and HA per sq cm respectively. This finding shows that the chemical nature of the contacting surface has a strong impact on cell behaviour. Schneider et al (2007) also reported that the cell adhesive property of a crosslinked multilayer film of chitosan-hyaluronan was significantly regulated by the chemical properties of the outermost layer of the film. These finding emphasizes the importance of optimizing the concentration and fabrication method in developing multi-polymer composites. Here, we also report that the surface modification method of coating was more effective in combining the cell adhesive and osteogenic properties of CHI, COL and HA leading to a significant enhancement of mineralization. Mao et al (2003) also found the surface modification method more effective than polyblend method for immobilizing hyaluronic acid on the surface of chitosan-gelatin membrane. The mixing ratio and the method of coating changed the surface property of the biomaterial, which altered the osteogenic property of the tripolymer coating. Enhancement of mineralization was very evident on plates coated by the surface modification method. These plates had varying concentrations of CHI and COL but a fixed concentration of HA. Therefore, the difference in the osteogenic potential among the different plates was mainly due to the difference in the concentration of CHI and COL as well as their interaction with the over layered HA. Interestingly, the maximum enhancement of osteoblast differentiation and 140

highest amount of calcium in the secreted matrix were seen on surface modified tripolymer plate, ([1CHI:1COL] 1HA)-S. The calcium assay also revealed better mineralization on the bipolymer combination of HA and COL than HA and CHI. Collagen synthesis is the primary function of differentiated osteoblast. The α1β1 and α2β1 integrins are the major collagen binding integrins. The α2β1 has a higher affinity for the fibrillar collagen type 1, the major protein constituent of bone. The α2β1 integrin interaction with collagen type 1 is a crucial signal for the induction of osteoblastic differentiation and matrix mineralization (Mizuno and Kuboki, 2001; Mizuno et al., 2000). Therefore in our study, the plate that had collagen coating showed marked increase in the differentiation potential and calcium mineralization. The plate without collagen showed less osteoblast differentiation and lower calcium mineralization ([1CHI: 0COL] 1HA)-S). Addition of HA and CHI further enhanced both osteoblast differentiation and mineralization. This hypothesis is further clarified in Fig. 8.6 when surface modified plates having collagen showed three fold higher calcium deposition ( ([ 1CHI:1COL]1HA )-S or ([1CHI:3COL]1HA) S) as compared to that of plate with no collagen ( ([1CHI:0COL]1HA)-S). This shows that COL is a crucial component for osteoblast differentiation that can be further enhanced by addition of HA and CHI. MSCs and osteoblasts express CD44 and HA act as the major ligand for CD44 (Goodison et al., 1999). CD44-HA binding mediates cell adhesion, migration (Zhu et al., 2006) and increases the cellular response to BMP7 (Peterson et al., 2004) which, together could contribute to the enhancement of mineralization by HA. CHI, which is considered osteocompatible and has got good film forming capacity (Hamilton et al., 2007) also contributed in creating a biomimetic coating for enhancing osteoblast differentiation and mineralization. Thus CHI, COL and HA when combined in the right proportion by an 141

appropriate method showed synergistic effect in enhancing osteoblast differentiation and mineral deposition. In bone healing process, adequate mineralization of the osteoid is essential for the formation of hard bone and healing of the fracture (Kalfas, 2001). So our tripolymer combination ([1CHI:1COL] 1HA)-S with adequate osteoconductivity and enhanced mineralization hold great promise for treating bone fracture. There are many reports showing enhanced osteointegration by surface modification of titanium implants with collagen type 1 (Morra, 2006, Rammelt et al., 2004). As our tripolymer coating showed three fold higher mineralization than collagen type 1 coating, it could be a better option for the surface modification of orthopaedic implants. To summarise, we have successfully demonstrated the synergistic effect of chitosan, collagen type 1 and hyaluronic acid on human osteogenesis as the combination enhanced the osteoblast differentiation and calcium deposition more effectively than the individual polymers. Our result affirms that this synergistic effect is stringently regulated or controlled by the mixing ratio and method of coating. The excellent osteogenic potential of this tripolymer coating can be exploited in therapeutic avenues like bone regeneration. We propose that this biomimetic coating could be employed effectively for the surface modification of implants and scaffolds used in orthopaedic applications to improve the osteoconductivity and osteointegration. They can also be adopted for fabricating three-dimensional scaffolds for cell based bone tissue engineering. 142